| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8aa526ab8413daf73be707d2d370b9e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_45a89bdf01e96f7fb649b342db783a1c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec0472de299a754beb0329657d3873bd |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate |
2002-01-22^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60ce74ff5bc1e161fde1c687e90bf058
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bd844db6be091c443c7046ab49b97a2b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d8da42e7f8eab2d2b8870fe4757777b |
| publicationDate |
2003-03-06^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03017981-A1 |
| titleOfInvention |
Controlled release formulation of clarithromycin or tinidazol |
| abstract |
The present invention relates to a controlled release pharmaceutical composition comprising amounts ranging from about 0.1 to about 4.5% w/w, of one or more of rate controlling cellulosic ether polymers. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2283824-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7943585-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007090595-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8168228-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005004919-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2004238253-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005004919-A3 |
| priorityDate |
2001-08-29^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |